Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Numinus Wellness Inc (NUMI.TO)

Numinus Wellness Inc (NUMI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,617
  • Shares Outstanding, K 320,552
  • Annual Sales, $ 23,180 K
  • Annual Income, $ -30,256 K
  • 60-Month Beta 1.78
  • Price/Sales 0.31
  • Price/Cash Flow N/A
  • Price/Book 2.08
Trade NUMI.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.02 on 07/11/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0250 unch
on 10/15/24
0.0350 -28.57%
on 10/08/24
-0.0050 (-16.67%)
since 09/13/24
3-Month
0.0250 unch
on 10/15/24
0.0500 -50.00%
on 08/08/24
-0.0200 (-44.44%)
since 07/15/24
52-Week
0.0250 unch
on 10/15/24
0.2000 -87.50%
on 01/08/24
-0.1300 (-83.87%)
since 10/13/23

Most Recent Stories

More News
Stocks in play: Numinus Wellness Inc.

Comments on the U.S. Food and Drug Administration's decision to not approve Lykos Therapeutics' new ...

NUMI.TO : 0.0250 (-16.67%)
Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and...

NUMIF : 0.0200 (-6.98%)
NUMI.TO : 0.0250 (-16.67%)
Stocks in play: Numinus Wellness Inc.

Announces execution of a letter of intent to acquire MedBright AI Investments Inc. by way of a statutory ...

NUMI.TO : 0.0250 (-16.67%)
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Q3 Fiscal 2024 Highlights Revenue of $4.3 million, a 1.9% decline over Q2 2024 Gross profit of $1.0 million, a 9.8% decline over Q2 2024 Cash position of $3.7...

NUMIF : 0.0200 (-6.98%)
NUMI.TO : 0.0250 (-16.67%)
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMI.TO : 0.0250 (-16.67%)
NUMIF : 0.0200 (-6.98%)
Numinus Wellness Announces Resignation of Director

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and...

NUMIF : 0.0200 (-6.98%)
NUMI.TO : 0.0250 (-16.67%)
Stocks in play: Numinus Wellness Inc.

Announces execution of a letter of intent to acquire MedBright AI Investments Inc. by way of a statutory ...

NUMI.TO : 0.0250 (-16.67%)
Numinus Wellness Announces Strategic Acquisition of MedBright AI

Plans name change to "Numinus Intelligence" leveraging its current revenue-generating operations to AI-enable mental health clinics across the U.S. The...

NUMIF : 0.0200 (-6.98%)
MBAI.CN : 0.0500 (-9.09%)
NUMI.TO : 0.0250 (-16.67%)
Numinus Clarifies Disclosures

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company advancing traditional and innovative...

NUMIF : 0.0200 (-6.98%)
NUMI.TO : 0.0250 (-16.67%)
Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and...

NUMIF : 0.0200 (-6.98%)
NUMI.TO : 0.0250 (-16.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted...

See More

Key Turning Points

3rd Resistance Point 0.0333
2nd Resistance Point 0.0317
1st Resistance Point 0.0283
Last Price 0.0250
1st Support Level 0.0233
2nd Support Level 0.0217
3rd Support Level 0.0183

See More

52-Week High 0.2000
Fibonacci 61.8% 0.1331
Fibonacci 50% 0.1125
Fibonacci 38.2% 0.0918
Last Price 0.0250
52-Week Low 0.0250

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar